Our Expert in Israel
No results available
AI patentability Israel is now one of the most pressing questions facing founders, in-house counsel and inventors building products on machine learning and generative systems. The short answer in 2026 is encouraging: AI-assisted and AI-generated inventions can be patented in Israel provided they meet the statutory requirements, but the way you name inventors, structure ownership and disclose your technology will make or break the application. This guide explains how the Israel Patent Office (ILPO) and the Patents Law, 5727-1967 treat AI-related inventions, where Israeli practice aligns with and diverges from the EPO and USPTO, and the exact filing steps startups should follow.
If you are moving fast toward a first filing, the practical checklists below are designed to be used immediately.
The question of AI patentability in Israel starts with a familiar test, not a new one. Israeli patent law does not have a separate regime for artificial intelligence. Instead, an invention that involves AI is assessed under the same substantive conditions that apply to any other invention under the Patents Law, 5727-1967. What matters is whether there is a concrete, reproducible technical contribution, not whether a human or a machine did the heavy lifting during conception.
In practice, this means an AI-related invention is judged on its technical merits: the problem it solves, the way it solves it, and the evidence that the solution works. A machine learning model used to improve the resolution of medical images, a trained system that optimises a manufacturing process, or an algorithm that enables a device to operate more efficiently can all qualify, so long as the claims describe a technical solution to a technical problem and the application enables a skilled person to reproduce it.
Under the Patents Law, a patentable invention must satisfy several cumulative conditions. It must be new (novel), meaning it is not part of the state of the art anywhere in the world before the filing or priority date. It must involve an inventive step, a non-obvious advance over what a person skilled in the relevant field would readily arrive at. It must be capable of industrial application, meaning it can be made or used in some kind of industry. And it must fall within patentable subject matter rather than an excluded category.
Under the Patents Law, discoveries, scientific theories, mathematical formulae, game rules, mental processes and computer programs “as such” are generally not patentable inventions in themselves; patentability turns on whether a concrete technical process or product is claimed.
For AI inventions, the inventive-step and subject-matter requirements tend to be the decisive battlegrounds. A bare mathematical model or an abstract algorithm, stated at a high level of generality, risks being treated as non-technical. The winning formulation ties the AI to a concrete technical effect: faster processing, reduced memory use, improved sensor accuracy, better control of a physical system, or a measurable improvement in a downstream technical output. When the claim is anchored to that technical effect and the specification proves it, AI patentability in Israel becomes a realistic prospect rather than a gamble.
It helps to distinguish two scenarios. In an AI-assisted invention, humans define the problem, design the architecture, select and curate the data, tune the system and interpret the results, the AI is a tool. Most real-world AI inventions fall here. Consider a team that designs a neural network to detect anomalies in industrial pumps; the humans conceived the solution and the network is the implementation. In a fully AI-generated invention, the system itself produces an output that the humans did not specifically foresee, for example, a generative model that proposes a novel chemical synthesis route or an unexpected mechanical geometry.
The crucial point for AI patentability in Israel is that this distinction affects inventorship and disclosure, not the threshold patentability of the underlying technical advance. A novel, non-obvious, industrially applicable solution does not become unpatentable merely because a model surfaced it, but you will need a human inventor to name, and you will need to describe the technical contribution with sufficient clarity.
Examiners frequently raise three objections against AI filings: that the claim is directed to non-patentable abstract or mathematical subject matter; that the inventive step is not demonstrated; and that the disclosure is insufficient to enable reproduction. Each has a practical answer. Recast abstract claim language around a concrete technical implementation and effect. Support inventive step with comparative experimental data. And expand the specification with enough architectural and training detail that a skilled reader could rebuild and run the system. These moves mirror the approach examiners at the EPO and USPTO expect for computer-implemented inventions, which gives Israeli applications a well-trodden path to follow.
This is the most searched question on AI inventorship in Israel, and the current answer is clear and consistent with the global mainstream: an AI system cannot be named as the inventor on an Israeli patent application. Inventorship is treated as a human attribute. The practical consequence is that every application, including one where a model did substantial conceptual work, must identify one or more natural persons as inventors.
The Patents Law frames the inventor as a person and ties rights such as the right to be named and the right to apply to natural persons and their legal successors. There is no provision contemplating a machine as an inventor, and Israel has limited published decisions directly addressing AI inventorship, so the statutory language and administrative practice are the primary guides. The position is reinforced by the high-profile DABUS litigation abroad, in which applicants sought to name an AI system as inventor. The EPO and the UK courts refused those applications on the basis that an inventor must be a natural person, and the USPTO adopted a comparable stance.
These outcomes signal international alignment, and Israeli practice sits firmly within that consensus.
Because AI inventorship in Israel must resolve to human beings, the task is to identify the people whose intellectual contribution produced the claimed invention. Ask who framed the technical problem, who designed or selected the model architecture, who curated and engineered the training data, who set the objectives and constraints, and who recognised and verified the inventive output. Those individuals are candidate inventors. Document their contributions contemporaneously, in lab notebooks, design records, commit histories and internal memos, so that inventorship can be defended if questioned.
Name all genuine joint inventors; over-naming or under-naming can create later validity and ownership problems. Where a model generated an unexpected result, the humans who configured the system and recognised the significance of the output are the proper inventors. A short internal statement of contribution for each named person, prepared at filing, is inexpensive insurance that supports the inventor designation throughout prosecution and any later dispute.
Inventorship and ownership disputes turn on evidence of who actually contributed. Contemporaneous records, version control logs, dated experiment data and signed agreements are decisive. Startups that maintain a disciplined paper trail from day one are far better placed if a co-founder, former employee or collaborator later asserts a claim.
Naming an inventor is not the same as owning the patent. Ownership of AI inventions in Israel is governed by a combination of statutory employee-invention rules and contract. For startups, getting the contractual architecture right is often more valuable than any single filing decision, because defective ownership can undermine investment, licensing and exit.
Under the Patents Law, inventions made by an employee in consequence of their service and during the period of service, so-called service inventions, generally belong to the employer, subject to the statute and any agreement. Note that compensation for service inventions is a distinct matter that can be contested before the Compensation and Royalties Committee, and parties frequently address it expressly by contract. This default is powerful, but it should never be relied upon alone. Clear written assignment clauses, confirmation-of-assignment provisions and acknowledgements that the employer owns inventions arising from employment should be built into every employment agreement.
Founders must ensure their own pre-incorporation work and the work of early technical hires is properly assigned to the company; unassigned founder IP is one of the most common and damaging problems uncovered in due diligence.
AI raises a distinction that classic patents rarely did: the difference between the model and its outputs. A startup may own the invention embodied in a patent but still depend on third-party models, pre-trained weights, open-source libraries or licensed datasets to build and operate it. Audit every such dependency for ownership of AI inventions in Israel and downstream freedom to operate. Confirm that training data was lawfully obtained and that its licence permits commercial use and patenting of derived inventions. Where you license in a model or dataset, secure the rights you need; where you license out, define the field of use, carve out background IP and address derived improvements.
These data-rights and background-IP questions are frequently the difference between a clean deal and a stalled one.
Disclosure is where many AI applications quietly fail. The Patents Law requires that the specification describe the invention in a manner sufficient for a person skilled in the art to carry it out. For software and machine learning inventions, high-level descriptions that read like marketing copy will not satisfy this requirement. Strong AI patentability in Israel depends on a specification that enables reproduction and substantiates the technical advance.
Aim to describe enough that a skilled reader could rebuild and operate the system. This typically includes the model architecture and its key components, the nature and characteristics of the training data (the type, scale, labelling and relevant pre-processing), the training regime and loss objectives, and the critical hyperparameters that make the invention work. You do not always need to disclose every line of production code or the entire dataset, but you must describe representative examples, inputs and outputs, and the steps a practitioner would take to achieve the claimed effect. Vague references to “a neural network” trained on “a dataset” to achieve “better results” invite insufficiency objections.
Patents demand disclosure; trade secrets demand secrecy. The two strategies are in tension, and part of smart filing is deciding what to patent and what to keep confidential. A practical approach is to patent the claimed technical architecture and effect that you need enforceable exclusivity over, while keeping genuinely proprietary assets, such as a unique production dataset, fine-tuning recipes or operational tuning that are hard to reverse-engineer, as trade secrets outside the specification. Describe data by its functional characteristics and representative samples rather than publishing proprietary corpora wholesale. Make these decisions deliberately before filing, because once an application publishes, the disclosed material is public.
Examiners and courts respond to data. Build the inventive-step case into the specification with comparative results: benchmarks against prior approaches, ablation studies showing which components drive the improvement, and quantified gains in accuracy, speed, efficiency or another technical metric. This experimental evidence rebuts obviousness arguments and demonstrates that the AI contribution produces a real technical effect rather than a trivial or predictable gain. For many AI filings, the comparative data section is the single most persuasive part of the application.
With the substantive rules in place, here is a practical, sequenced filing plan tailored to startups pursuing AI patentability in Israel while preserving international options and conserving cash.
Claims should anchor the AI to a concrete technical implementation and effect. Avoid framing a claim as a bare mathematical method or a result divorced from technical means. Instead, recite the system, the data flow and the technical outcome. Useful structural approaches include method claims tied to a technical process, system or apparatus claims reciting the components, and computer-readable medium claims. For example, rather than claiming “a method of predicting failures using a neural network,” claim “a method of controlling an industrial pump, comprising receiving sensor data, processing the sensor data with a trained model having [defined architecture] to generate a failure-risk signal, and adjusting an operating parameter of the pump in response to the signal to reduce downtime.”
Draft a layered claim set: independent claims capturing the broad technical concept, and dependent claims capturing architecture specifics, data-processing steps, training features and alternative implementations. Avoid red-flag phrases that signal abstraction, such as claims reciting only “an algorithm for” a result, “a mathematical model that” outputs a value, or purely mental-step language. Each independent claim should map to a technical effect that the specification demonstrates with data.
Most startups should file a first application to establish a priority date, then use the 12-month priority window to file internationally. A PCT application filed within 12 months of the priority date preserves the option to enter national or regional phases in major markets, including the US and Europe, while deferring the larger cost of multiple filings. Because the EPO and USPTO apply their own software and AI examination practices, align your disclosure and claim strategy to those standards from the outset so a single well-built specification travels well across jurisdictions.
Where speed matters, for example, to support fundraising or to deter a fast-moving competitor, the ILPO offers accelerated examination options, and Israel participates in Patent Prosecution Highway (PPH) arrangements with a number of offices, which can bring an application to grant more quickly than the standard track. Discuss eligibility and timing with your patent attorney early, because the evidence and claim quality needed to survive faster examination are the same, only on a compressed timeline. Responding to office actions for AI inventions is often most effective when supported by expert declarations and fresh comparative data that address the examiner’s specific objection rather than generic argument.
| Issue | Israel (ILPO) | EPO | USPTO |
|---|---|---|---|
| Can AI be named inventor? | No, inventorship attributed to natural persons under the Patents Law | No, inventor must be a natural person (DABUS refused) | No, inventor must be a natural person (DABUS refused) |
| Statutory inventor requirement | Human inventor named; rights flow to persons and successors | Human inventor required under the European Patent Convention | Human inventor required under US law |
| Treatment of AI-generated inventions | Patentable if standard conditions met and technical effect shown; a human inventor must be named | Patentable as computer-implemented inventions with a technical character/effect | Patentable subject to eligibility analysis; AI-assisted inventions supported by guidance |
| Disclosure expectations | Enabling disclosure sufficient for a skilled person to reproduce; architecture, data and key parameters | Detailed enabling disclosure of the technical implementation | Enablement and written-description support, with evidence of technical improvement |
| Notable cases / guidance | Statutory text and ILPO practice primary; limited AI-specific case law | DABUS decisions; Guidelines for Examination on computer-implemented inventions | DABUS position; dedicated AI initiative and examination guidance |
The practical takeaway is reassuring: the three systems are closely aligned on the key questions. Because Israel, the EPO and the USPTO all require a human inventor and all reward applications that tie AI to a demonstrated technical effect, a single, well-constructed Israeli application built to these shared standards can serve as a strong foundation for international filing.
The following anonymised, hypothetical scenarios illustrate how the principles above come together.
To move from strategy to action on AI patentability in Israel, founders should take the following immediate steps:
Before a first meeting with counsel, prepare the invention disclosure, your experimental data, a list of inventors, copies of relevant contracts and licences, and a short note on commercial priorities and target markets. This preparation shortens the path to a strong first filing. For deeper dives, see our planned guides on how to draft claims for AI-assisted inventions in Israel, ownership, licensing and data-use agreements for AI models in Israel, and accelerated prosecution for AI inventions at the Israel Patent Office.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Jeremy Ben David at JMB Davis Ben David, a member of the Global Law Experts network.
AI patentability in Israel is well within reach for startups that approach it methodically. The substantive test is the familiar one, novelty, inventive step and industrial application, and AI-related inventions succeed when they are framed around a concrete technical effect, supported by comparative evidence and described in enough detail to enable reproduction. Remember the two defining rules for 2026: a human must be named as inventor, and ownership depends on disciplined contracts layered on top of the statutory employee-invention regime. Fix your ownership chain early, document your inventors and evidence, decide deliberately what to patent and what to keep secret, and build a single strong specification that travels across Israel, the EPO and the USPTO. For tailored help, consult an Intellectual Property lawyer in Israel, hire a specialist and review the author profile for Jeremy Ben David, Israel Patent Attorney. Further cluster guides, including AI patentability in other jurisdictions and ownership, licensing and data-use agreements for AI models in Israel, expand on the strategies above.
posted 3 minutes ago
posted 25 minutes ago
posted 44 minutes ago
posted 1 hour ago
posted 1 hour ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 3 hours ago
posted 3 hours ago
posted 3 hours ago
posted 4 hours ago
No results available
Find the right Legal Expert for your business
Send welcome message